Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

Dendreon CEO to step down

John Johnson to leave next summer as Provenge sales stall

- PMLiVE

Merck agrees $3.85bn deal for hepatitis specialist Idenix

Opens up direct challenge to Gilead

- PMLiVE

Cubist publishes positive data on novel antibiotic

Sivextro offers once-daily alternative for skin infections

- PMLiVE

SMC: Celgene’s Abraxane ‘too expensive’ for Scotland

But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta

- PMLiVE

Horizon adds AZ’s Galbraith to board

UK genomics company also appoints Susan Searle

- PMLiVE

MSA Market Media expands

Ben Mansfield joins as client services director and digital consultant

- PMLiVE

Grünenthal launches pain initiatives in Europe

Launches website for patients in Spain and grants German contract to B & F Brüggemann

EU flag

EFPIA: pharma must play key role in healthcare reform

Trade body publishes strategy to put industry at heart of economic growth

- PMLiVE

Myeloma UK and M3 launch education programme

Will use Doctors.net.uk online network

- PMLiVE

FDA approves Biogen Idec’s haemophilia drug

Eloctate now available to help control and prevent bleeding episodes

- PMLiVE

EMA adaptive licensing project gathers pace

Regulator picks two drugs to pilot early access scheme

- PMLiVE

Former Merck & Co exec to lead Seres

Roger Pomerantz was senior VP at pharma giant

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links